Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Chinese Patent Office
Argus Health
Daiichi Sankyo
Cantor Fitzgerald

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,367,480

« Back to Dashboard

Which drugs does patent 6,367,480 protect, and when does it expire?

Patent 6,367,480 protects VISIONBLUE and is included in one NDA.

Summary for Patent: 6,367,480
Title: Methods for visualizing the anterior lens capsule of the human eye
Abstract:Use of trypan blue in the manufacture of a composition to enhance the visualisation of the anterior lens capsule of the eye during removal of a cataractous lens and lens replacement procedures is described. Also described are methods for the visualisation of the anterior lens capsule and processes for cataract treatment.
Inventor(s): Coroneo; Minas Theodore (Randwick, NSW 2031, AU)
Assignee:
Application Number:09/426,769
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,367,480
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 6,367,480

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up A METHOD OF APPLYING TRYPAN BLUE ONTO AN OUTER SURFACE OF THE ANTERIOR LENS CAPSULE TO FACILITATE REMOVAL OF THE LENS SUBSTANCE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
McKinsey
UBS
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.